News - Glenmark Pharmaceuticals

Filter

Current filters:

Glenmark Pharmaceuticals

Popular Filters

Glenmark gets $4 million milestone in Forest collaboration

Glenmark gets $4 million milestone in Forest collaboration

27-03-2014

Indian drugmaker Glenmark Pharmaceuticals has informed the Stock Exchange today that the company through…

FinancialForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingPharmaceutical

Mayne Pharma signs up deals to market Subacap in Europe

12-08-2013

Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Briefs: Glenmark challenges Bayer patent; FDA delays Merck & Co's sugammadex

18-03-2013

Indian drugmaker Glenmark Generics confirms that it seeking US Food and Drug Administration approval…

BayerBridionDermatologicalsFinacea GelGenericsGlenmark PharmaceuticalsMerck & CoNeurologicalNorth AmericaPatentsPharmaceuticalRegulationsugammadex

ICDR rules in favor of Glenmark over Crofelemer

23-08-2012

Indian drugmaker Glenmark Pharmaceuticals saw its shares rise 2.3% to 415 rupees yesterday after the…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalNapo PharmaceuticalsPharmaceutical

Salix files Crofelemer NDA as spat with Napo moves to Glenmark

15-12-2011

USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalLicensingNapo PharmaceuticalsPharmaceuticalRegulationSalix Pharmaceuticals

Glenmark sells rights to Crohn’s drug to Sanofi for up to $613 million

17-05-2011

In a second licensing deal between the companies, Indian drugmaker Glenmark Pharmaceuticals, through…

Anti-Arthritics/RheumaticsGlenmark PharmaceuticalsLicensingPharmaceuticalSanofi

Back to top